Clinical Trial Update: A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 study of eszopiclone in insomnia related to major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Major Depressive Disorder

Drugs mentioned

• Lunesta (eszopiclone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Insomnia, Depressive Disorder, Major | Phase 3 | Status: COMPLETED